Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis

Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis

To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematological response of patients treated with azacytidine...

Full description

Bibliographic Details
Main Authors: Tomoya Maeda, Akira Matsuda, Chie Asou, Daisuke Okamura, Ken Tanae, Mika Kohri, Maho Ishikawa, Naoki Takahashi, Kunihiro Tsukasaki, Nobutaka Kawai, Norio Asou, Masami Bessho
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Leukemia Research Reports
Subjects:
Myelodysplastic Syndromes
Wilms’ tumour 1
WT1
azacytidine
hypomethylating agent
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048920300376

Internet

http://www.sciencedirect.com/science/article/pii/S2213048920300376

Similar Items